Medical Communications

Showing 15 posts of 6411 posts found.

nhs_trees

Mental health services ‘remain rooted in the past’, finds report

July 20, 2017 Medical Communications CQC, NHS, biotech, drugs, mental health, pharma, pharmaceutical

A three year report by the Care Quality Commission (CQC) has found that though compassionate care is being offered broadly …
nhs_parliament_2_4

Cost-cutting not the way to drive value for the NHS, finds independent committee

July 19, 2017 Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical

An independent steering committee has compiled a report looking at how more can be delivered from the NHS budget, without …
hoiland

Radius bolsters leadership with appointment of Novo Vet

July 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Radius, biotech, drugs, pharma, pharmaceutical

Jesper Høiland has been revealed as the new President and Chief Executive Officer of Radius. The news comes shortly after …
social-media-550766_640

Pharmafocus wants to hear from you!

July 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, biotech, drugs, healthcare, pharma, pharmaceutical

We are always looking for new ways to improve the next issue of Pharmafocus, and now we’re planning a new …
wood-1

GSK completes further high-profile staff acquisition

July 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer Senior Vice President of Medicinal Sciences, Tony Wood, has agreed to join GSK, as broken by FierceBiotech. The appointment …
brexit-referendum-uk-1468255193y2p

What pharma should know about the European Unitary Patent in light of Brexit

July 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, biotech, brexit, drugs, healthcare, pharma, pharmaceutical

The departure of the United Kingdom from the European Union, dubbed “Brexit,” has sparked significant economic global uncertainty. Two Brexit-related …
pascal_soriot

AstraZeneca’s Soriot Teva switch scotched

July 17, 2017 Medical Communications, Sales and Marketing AstraZeneca, Soriot, Teva, biotech, drugs, pharma, pharmaceutical

The rumours, beginning with a report by Israeli newspaper Calcalist, had suggested that Pascal Soriot, CEO of AstraZeneca, appeared to …

UK government announces £86 million funding as tentative AAR step

July 14, 2017 Medical Communications NHS, UK government, biotech, drugs, pharma, pharmaceutical

The UK government has revealed that it will apportion £86 million to help the assessment of new technologies and increase …
brexit_2

What Brexit means for drug regulation

July 14, 2017 Medical Communications, Sales and Marketing biotech, brexit, drugs, healthcare, pharma, pharmaceuticals, regulation

The pharmaceutical sector is one of the most tightly regulated industries, and most of the rules that govern the daily …
document-428331_960_720

Independent panel advise FDA to apply different framework to opioid painkillers

July 14, 2017 Medical Communications FDA, biotech, drugs, opioid, opioid epidemic, pharma, pharmaceutical

Over a year ago, the Obama administration asked the National Academies of Sciences, Engineering, and Medicine to advise them on …
fda2outsideweb

FDA unanimously recommends Mylan and Biocon’s Herceptin biosimilar

July 14, 2017 Manufacturing and Production, Medical Communications, Sales and Marketing Biocon, Herceptin, Mylan, biosimilar, biotech, drugs, healthcare, life sciences, pharma, pharmaceuticals

Mylan and Biocon have revealed that their biosimilar version of Roche and Genentech’s Herceptin (trastuzumab) has received unanimous recommendation from …

J&J uses FDA Priority Review Voucher to snag psoriasis approval

July 14, 2017 Medical Communications, Sales and Marketing Janssen, Johnson & Johnson, Tremfya, biotech, drugs, pharma, pharmaceutical

The FDA has handed out another approval, as the agency now easily surpasses last year’s figure of 22 already, this …
The Gateway to Local Adoption Series

Latest content